FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043938419> ?p ?o ?g. }

• W2043938419 endingPage "984" @default.
• W2043938419 startingPage "981" @default.
• W2043938419 abstract "Background/purpose A common trait among cancers is the increased level of glycolysis despite adequate oxygen levels to support aerobic respiration. This has been shown repeatedly in different human malignancies. Glycolysis inhibitors, especially 3-bromopyruvate, have been shown to be effective chemotherapeutic agents. The effect of glycolysis inhibition upon chemotherapy resistance is relatively unknown. Methods Wild-type and doxorubicin-resistant lines of neuroblastoma (SK-N-SH and SK-N-Be(2)C) were used in this study. Using an MTT assay, the IC50 of 3-BrPA was determined. Subsequently, doxorubicin-resistant cell lines were treated with 3-bromopyruvate, doxorubicin, and 3-bromopyruvate with doxorubicin. Additionally, a luminescence ATP detection assay was used to measure intracellular ATP levels, and a lactate assay was used to determine intracellular lactate levels. All experiments were repeated in hypoxic conditions. Results Treatment with 3-bromopyruvate and doxorubicin significantly decreased the mean cell viabilities at 24, 48, and 72 hours in normoxic conditions. A similar response was replicated in hypoxic conditions. Treatment with 3-bromopyruvate significantly decreased intracellular ATP and lactate levels. Conclusion Glycolysis inhibitors such as 3-bromopyruvate could prove to become an effective means by which chemotherapy resistance can be overcome in human neuroblastoma." @default.
• W2043938419 created "2016-06-24" @default.
• W2043938419 creator A5006375381 @default.
• W2043938419 creator A5013618564 @default.
• W2043938419 creator A5027650578 @default.
• W2043938419 creator A5049966575 @default.
• W2043938419 creator A5055562797 @default.
• W2043938419 creator A5068782130 @default.
• W2043938419 date "2014-06-01" @default.
• W2043938419 modified "2023-10-18" @default.
• W2043938419 title "Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma" @default.
• W2043938419 cites W1565284520 @default.
• W2043938419 cites W1986154783 @default.
• W2043938419 cites W2001144536 @default.
• W2043938419 cites W2008772139 @default.
• W2043938419 cites W2030368798 @default.
• W2043938419 cites W2039015357 @default.
• W2043938419 cites W2045102424 @default.
• W2043938419 cites W2072451938 @default.
• W2043938419 cites W2097878215 @default.
• W2043938419 cites W2113559991 @default.
• W2043938419 cites W2122816851 @default.
• W2043938419 cites W2145529521 @default.
• W2043938419 doi "https://doi.org/10.1016/j.jpedsurg.2014.01.037" @default.
• W2043938419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24888847" @default.
• W2043938419 hasPublicationYear "2014" @default.
• W2043938419 type Work @default.
• W2043938419 sameAs 2043938419 @default.
• W2043938419 citedByCount "25" @default.
• W2043938419 countsByYear W20439384192014 @default.
• W2043938419 countsByYear W20439384192015 @default.
• W2043938419 countsByYear W20439384192016 @default.
• W2043938419 countsByYear W20439384192017 @default.
• W2043938419 countsByYear W20439384192018 @default.
• W2043938419 countsByYear W20439384192019 @default.
• W2043938419 countsByYear W20439384192020 @default.
• W2043938419 countsByYear W20439384192021 @default.
• W2043938419 countsByYear W20439384192022 @default.
• W2043938419 crossrefType "journal-article" @default.
• W2043938419 hasAuthorship W2043938419A5006375381 @default.
• W2043938419 hasAuthorship W2043938419A5013618564 @default.
• W2043938419 hasAuthorship W2043938419A5027650578 @default.
• W2043938419 hasAuthorship W2043938419A5049966575 @default.
• W2043938419 hasAuthorship W2043938419A5055562797 @default.
• W2043938419 hasAuthorship W2043938419A5068782130 @default.
• W2043938419 hasConcept C126322002 @default.
• W2043938419 hasConcept C20251656 @default.
• W2043938419 hasConcept C202751555 @default.
• W2043938419 hasConcept C2776694085 @default.
• W2043938419 hasConcept C2776715637 @default.
• W2043938419 hasConcept C2780783641 @default.
• W2043938419 hasConcept C2781303535 @default.
• W2043938419 hasConcept C502942594 @default.
• W2043938419 hasConcept C54355233 @default.
• W2043938419 hasConcept C55493867 @default.
• W2043938419 hasConcept C55885012 @default.
• W2043938419 hasConcept C62231903 @default.
• W2043938419 hasConcept C71924100 @default.
• W2043938419 hasConcept C79879829 @default.
• W2043938419 hasConcept C81885089 @default.
• W2043938419 hasConcept C86803240 @default.
• W2043938419 hasConcept C98274493 @default.
• W2043938419 hasConceptScore W2043938419C126322002 @default.
• W2043938419 hasConceptScore W2043938419C20251656 @default.
• W2043938419 hasConceptScore W2043938419C202751555 @default.
• W2043938419 hasConceptScore W2043938419C2776694085 @default.
• W2043938419 hasConceptScore W2043938419C2776715637 @default.
• W2043938419 hasConceptScore W2043938419C2780783641 @default.
• W2043938419 hasConceptScore W2043938419C2781303535 @default.
• W2043938419 hasConceptScore W2043938419C502942594 @default.
• W2043938419 hasConceptScore W2043938419C54355233 @default.
• W2043938419 hasConceptScore W2043938419C55493867 @default.
• W2043938419 hasConceptScore W2043938419C55885012 @default.
• W2043938419 hasConceptScore W2043938419C62231903 @default.
• W2043938419 hasConceptScore W2043938419C71924100 @default.
• W2043938419 hasConceptScore W2043938419C79879829 @default.
• W2043938419 hasConceptScore W2043938419C81885089 @default.
• W2043938419 hasConceptScore W2043938419C86803240 @default.
• W2043938419 hasConceptScore W2043938419C98274493 @default.
• W2043938419 hasIssue "6" @default.
• W2043938419 hasLocation W20439384191 @default.
• W2043938419 hasLocation W20439384192 @default.
• W2043938419 hasOpenAccess W2043938419 @default.
• W2043938419 hasPrimaryLocation W20439384191 @default.
• W2043938419 hasRelatedWork W1555428651 @default.
• W2043938419 hasRelatedWork W2029086463 @default.
• W2043938419 hasRelatedWork W2043938419 @default.
• W2043938419 hasRelatedWork W2093599698 @default.
• W2043938419 hasRelatedWork W2144209664 @default.
• W2043938419 hasRelatedWork W2362699985 @default.
• W2043938419 hasRelatedWork W2416964709 @default.
• W2043938419 hasRelatedWork W2547646693 @default.
• W2043938419 hasRelatedWork W2754839811 @default.
• W2043938419 hasRelatedWork W3031613969 @default.
• W2043938419 hasVolume "49" @default.
• W2043938419 isParatext "false" @default.
• W2043938419 isRetracted "false" @default.
• W2043938419 magId "2043938419" @default.

• next